Results 121 to 130 of about 240,410 (292)

Medication errors in emergency departments: is electronic medical record an effective barrier?

open access: yesEinstein (São Paulo)
Objective: To compare medication errors in two emergency departments with electronic medical record, to two departments that had conventional handwritten records at the same organization.
Marina Vaidotas   +6 more
doaj   +1 more source

A Prescription for Safety: Medication Error Reporting, Education, and Advocating for Change

open access: yesPatient Safety, 2021
In 1974, pharmacist Michael Cohen learned of a serious adverse event with insulin at a hospital and began sharing information about it with other pharmacists to prevent the error from happening again. Twenty years later, he founded the Institute for Safe
Michael R Cohen, Eugene Myers
doaj  

Engineered extracellular vesicles enriched with the miR‐214/199a cluster enhance the efficacy of chemotherapy in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang   +12 more
wiley   +1 more source

Advancing Patient Safety in the U.S. Department of Veterans Affairs [PDF]

open access: yes, 2011
As part of a systemwide transformation, the VA formed its National Center for Patient Safety to foster an organizational culture of safety within its nationwide network of hospitals and outpatient clinics.
Deborah Chase, Douglas McCarthy
core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

BARRIERS AND INCENTIVES TO REPORTING MEDICATION ERRORS AND NEAR MISSES IN A UNIVERSITY HOSPITAL: PERCEPTION OF DOCTORS, NURSES AND PHARMACISTS

open access: yesJornal de Assistência Farmacêutica e Farmacoeconomia
OBJECTIVES: The goal of this study is to understand the barriers and incentives to the reporting of medication errors and near misses according to the perception of doctors, nurses and pharmacists, and to explore the understanding of the institution's ...
Juliana Ferreira Fernandes Machado   +2 more
doaj   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma

open access: yesMolecular Oncology, EarlyView.
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic   +5 more
wiley   +1 more source

Memorial Healthcare System: A Public System Focusing on Patient- and Family-Centered Care [PDF]

open access: yes, 2010
Outlines a successful multifaceted strategy that includes personalizing healthcare quality, monitoring and reporting of performance data, careful design of care processes, and the system's vertical and horizontal integration.
Jennifer N. Edwards
core  

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

open access: yesMolecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy